Genomics

Dataset Information

0

Gene expression from tuft cells under scopolamine treatment


ABSTRACT: In our study, we investigated the effect of muscarinic receptor blockade on murine intestinal stem cell activity and differentiation. Following pharmacologic (scopolamine) and genetic muscarinic receptor interruption (M3R-KO, M1R-KO; Vil-Cre x M3R fl/fl, Vil-Cre x M1R fl/fl mice, respectively), we observe a selective, significant expansion of DCLK1-positive tuft cells. This is primarily sensed by endocrine Prox1-positive cells (Prox1-CreERT2 x M3R fl/fl mice), while Lgr5-positive ISCs respond with a reduction of their cellular activity (Lgr5-EGFP-IRES-CreERT2 x M3R fl/fl mice). To characterize expanding tuft cells in more detail, adult BAC transgenic DCLK1-DTR-ZSgreen reporter mice generated in our lab were treated with scopolamine or sodium chloride as controls (Sham) for 7d and live jejunal EPC-positive/ZSgreen-positive cells sorted. Extracted total RNA from sorted ZSgreen-positive cells of scopolamine- and sham-treated mice was sequenced. Further analysis revealed that expanding tuft cells orchestrate an increase in mucosal acetylcholine, which maintained intracellular signaling pathways such as p-ERK/ERK 1/2 or TCF-1/7. Finally, acute irradiation injury was employed to investigate the importance of this regulatory circuit for tissue homeostasis. Indeed, tissue injury in Vil-Cre x M3R fl/fl mice resulted in a severe reduction of epithelial DCLK1-positive tuft cells, concomitant to reduced mucosal Ach levels as well as intracellular PI3K-/p-ERK levels. Therefore, DCLK1-positive tuft cells appear essential for the maintenance of a regular intestinal cholinergic niche.

ORGANISM(S): Mus musculus

PROVIDER: GSE138365 | GEO | 2019/11/01

REPOSITORIES: GEO

Similar Datasets

2020-05-07 | GSE146020 | GEO
2021-02-19 | GSE118853 | GEO
2023-10-14 | GSE245188 | GEO
2024-01-08 | GSE224543 | GEO
2023-12-31 | GSE210973 | GEO
2022-02-09 | GSE196220 | GEO
2023-12-04 | GSE245074 | GEO
2021-10-31 | GSE156031 | GEO
2023-02-27 | PXD039083 | Pride
2022-09-27 | PXD036977 | Pride